Therefore, it remains a topic of further study if NCAM-positive plasma EVs mainly originate from the brain and can be targeted for biomarker discovery of neurological and neurodevelopmental disorders, including autism spectrum disorder. The gene discussed is NCAM1; the disease is neurodevelopmental disorder.